Alpa Laboratories Limited engages in the manufacture and sale of drugs and chemicals in India. It offers ethical, generic, and over the counter medicines. The company provides tablets, capsules, injections, syrups, ointments, creams, eye drops, and other dosage forms for human and veterinary healthcare, as well as aquaculture products, including probiotics, deodorizer, minerals, feed supplements, and disinfectant.
Alpa Laboratories Limited (ALPA) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The ALPA share price is ₹53.74 (-1.32% today), with a market capitalisation of ₹1B and a price-to-earnings (P/E) ratio of 32.0. MarketRipple tracks the ALPA investment thesis, the ripple-chain impact of market events on Alpa Laboratories Limited, and the Healthcare sector outlook.
Open
₹54.49
High
₹54.49
Low
₹51.71
Prev. Close
₹54.46
52W High
₹92.50
52W Low
₹46.10
Day range
₹51.71–₹54.49
52-week range
₹46.10–₹92.50
Volume
7K
P/E
32.0
ROE
8.1%
D/E
0.01
Margin
3.8%
Alpa Laboratories Limited (NSE: ALPA) is currently trading at ₹53.74 (-1.32%).
Alpa Laboratories Limited's market capitalization is ₹1B.
Alpa Laboratories Limited's price-to-earnings (P/E) ratio is 32.0.
Alpa Laboratories Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).